{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26"}]}],"title":"6 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"24"}]}],"title":"1 Year"},{"categories":[{"measurements":[{"groupId":"OG000","value":"19"}]}],"title":"2 Years"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}],"title":"3 Years"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16"}]}],"title":"4 Years"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"}]}],"title":"5 Years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"}],"units":"Participants"}],"description":"Number of patients surviving up to five years post-transplant.","groups":[{"description":"See Detailed Description\n\nCyclosporine: Given IV or PO\n\nDasatinib: Given PO\n\nFludarabine Phosphate: Given IV\n\nImatinib Mesylate: Given PO\n\nMycophenolate Mofetil: Given PO\n\nNilotinib: Given PO\n\nNonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Undergo nonmyeloablative allogeneic PBSC transplantation\n\nPeripheral Blood Stem Cell Transplantation: Undergo allogeneic PBSC transplantation\n\nTherapeutic Allogeneic Lymphocytes: Given IV\n\nTotal-Body Irradiation: Undergo TBI","id":"OG000","title":"Treatment (Allogeneic Nonmyeloablative HSCT)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Assessed up to 5 years","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"Participants"}